COO, CFO AND SECRETARY
Sat, Feb 15, 2025
Feb 15
1,375 shares @ $0.00
Decreased holdings by -25.00%
Net across this filing: +5.20% (+12,505 shares)
60th largest trade (out of 143)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +5.2% (+12,505 shares)
69% win rate · +5.4% median edge vs SPY (13 trades, 90-day · small sample)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology